JPI Healthcare Co Ltd
0010V0
Company Profile
Business description
JPI Healthcare Co Ltd focuses on the development and manufacture of core components and imaging devices related to X-ray-based imaging diagnosis. It also manufactures and sells next-generation medical imaging devices such as digital tomosynthesis (2.5D) and mobile low-dose, high-precision CT (3D) as differentiated products compared to other products in the existing market. Its products include: X-Ray grid System, Imaging Solutions, and Trading.
Contact
28 Digital-ro 33-gil
No. 608, Guro-dong, Urim E-Biz Center 1
Guro-gu
Seoul
KORT: +82 221082580
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
141
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,149.20 | 24.10 | 0.26% |
| CAC 40 | 8,263.87 | 355.13 | 4.49% |
| DAX 40 | 24,080.63 | 1,159.04 | 5.06% |
| Dow JONES (US) | 47,909.92 | 1,325.46 | 2.85% |
| FTSE 100 | 10,608.88 | 260.09 | 2.51% |
| HKSE | 25,808.00 | 85.02 | -0.33% |
| NASDAQ | 22,634.99 | 617.14 | 2.80% |
| Nikkei 225 | 55,861.55 | 446.87 | -0.79% |
| NZX 50 Index | 13,278.48 | 24.54 | 0.19% |
| S&P 500 | 6,782.81 | 165.96 | 2.51% |
| S&P/ASX 200 | 8,949.70 | 34.30 | 0.38% |
| SSE Composite Index | 3,965.70 | 29.30 | -0.73% |